Rallybio Corp. (RLYB) - Forvard P/S multiplikatori

Rallybio Corp. (RLYB) tovar belgisi

Rallybio Corporation (RLYB) uchun oldingi P/S koeffitsiyenti dinamikasi klinik sinovlarning muvaffaqiyati va sotib olish istiqbollari bilan bog'liq. Shu bilan birga, 194.30 ushbu metrikaning joriy qiymatini ifodalaydi. Aktivlar qiymatining o'sishi kamyob homila patologiyalari uchun noyob terapiyalarning ishlab chiqilishi bilan ta'minlanmoqda. Jarayon barqarorligi rejalashtirilgan laboratoriya operatsiyalari va pilot partiyalarni ishlab chiqarish uchun tashqi pudratchi imkoniyatlarini qayta shakllantirish orqali saqlanmoqda.

RLYB Rallybio Corp: Narxning prognoz qilingan daromadga nisbati 10.08.2024 - 15.11.2026 oraligʻida

RLYB (Rallybio): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- bozor narxi va tahlilchilarning maqsadli narxlari:
- bozor kapitallashuvi ko'rsatkichlari:
Kompaniyaning jamlanma tahliliyoti:Rallybio Corp RLYB
rallybio.com tomonidan chiqariladigan mahsulotlar

Forward P/S joriy bozor kapitalizatsiyasini prognoz qilingan daromadlar bilan solishtirib, kelajakdagi pul oqimlariga bo'lgan bozor kutuvlarini va rahbariyat ko'rsatmalariga bo'lgan ishonch darajasini aks ettiradi. Rallybio Corporation (RLYB) uchun, qayerda biznes qiymati kamyob dorilar uchun sovuq zanjir ta'minotining murakkabligiga bog'liq, GURU.Markets platformasidagi kutilayotgan P/S ko'rsatkichi investorlar logistika infratuzilmasining samaradorligini va portfelning tijoratlashtirish salohiyatini qanday baholashini namoyish etadi.

Raqobatdosh kompaniyalar tahlili

Forvard P/S multiplikatori HLN (Haleon PLC)|Forvard P/S multiplikatori Kenvue Corp KVUE|Verona Pharma PLC - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati jyongbio.com|LGND: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati AMRX|Narxning prognoz qilingan daromadga nisbati Perrigo Company|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alvotech ALVO|Forvard P/S multiplikatori LQDA|GLPG: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori ANIP (ANI Pharmaceuticals, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati MannKind Corp (MNKD)|AMPH: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx PCRX (Pacira)|ARS Pharmaceuticals (SPRY) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati TBPH|AQST (Aquestive Corp) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori scPharmaceuticals Inc. (SCPH)|Forvard narx/daromad multiplikatori TECX (Tectonic Therapeutic, Inc.)|TNXP (Tonix Pharmaceuticals Holding) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati SXT Pharmaceuticals SXTC|Sotuvga nisbatan forvard narx EPRX|BHST - Narxning prognoz qilingan daromadga nisbati|eXoZymes (EXOZ) - Forvard narx/daromad multiplikatori|ORMP: Forvard P/S multiplikatori|ENTX: Narxning kutilayotgan daromadga nisbati|HYFT (ipatherapeutics.com) - Forvard P/S multiplikatori|Forvard P/S multiplikatori ABVC BioPharma|Narxning prognoz qilingan daromadga nisbati Cumberland Pharmaceuticals Inc. (CPIX)|QNTM (Quantum BioPharma Ltd.) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori FGEN (fibrogen.com)|Telomir Pharmaceuticals (TELO) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|RANI - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Synergy CHC SNYR|LEXX: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Pulmatrix Inc|PTHL (Pheton Holdings) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Aptorum Group Limited APM|Narxning prognoz qilingan daromadga nisbati Lyra Therapeutics (LYRA)|Forvard narx/daromad multiplikatori Impact BioMedical Inc IBO|Narxning prognoz qilingan daromadga nisbati tnfpharma.com TNFA|Sotuvga nisbatan forvard narx YCBD|PainReform Ltd - Forvard P/S multiplikatori|Altamira Therapeutics Ltd (CYTO) - Forvard narx/daromad multiplikatori|lipella.com (LIPO) - Narxning prognoz qilingan daromadga nisbati|OptiNose (OPTN) - Forvard P/S multiplikatori|PIRS (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|PROC: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Petros Pharmaceuticals, Inc. (PTPI)|Forvard P/S multiplikatori Qilian International Corp (QLI)|ACELYRIN, Inc. - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori tffpharma.com TFFP